Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome
Lipografting Versus Steroid Injections for Treatment of Primary Mild to Moderate Carpal Tunnel Syndrome
Sponsor: Columbia University
Suspended
lack of funding
Listed as NCT03722303, this EARLY_PHASE1 trial focuses on Carpal Tunnel Syndrome and remains suspended. Sponsored by Columbia University, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Suspended EARLY_PHASE1
-
Oct 2024 — Oct 2025 [monthly]
Suspended EARLY_PHASE1
Status: Unknown → Suspended
-
Sep 2024 — Oct 2024 [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Recruiting EARLY_PHASE1
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
- Orthopaedic Scientific Research Foundation
For direct contact, visit the study record on ClinicalTrials.gov .